micro-community-banner
 
  • Saved
Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review - PubMed

Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39275243/

Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD). During pregnancy, physiological changes elevate cholesterol and triglyceride levels to support fetal development, which can exacerbate pre-existing conditions and...

Dyslipidemia during pregnancy increases ASCVD risk and complications. Management, including dietary adjustments and selective pharmacological interventions, requires a personalized, multidisciplinary approach to balance maternal and fetal health, especially in inherited dyslipidemia.

  • Saved
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions - PubMed

Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38250316/

Adiponectin, an adipose-derived hormone, plays a pivotal role in glucose regulation and lipid metabolism, with a decrease in circulating adiponectin levels being linked to insulin resistance and prediabetes. This review...

This review explores adiponectin's role in glucose regulation, insulin sensitivity, and lipid metabolism, highlighting strategies to boost its levels for managing prediabetes, and addressing challenges in clinical translation.

  • Saved
Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects - PubMed

Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38642715/

Alzheimer's and Parkinson's diseases are two of the most frequent neurological diseases. The clinical features of AD are memory decline and cognitive dysfunction, while PD mainly manifests as motor dysfunction...

Dysregulated lipid metabolism exacerbates Alzheimer's and Parkinson's diseases through various mechanisms, with emerging lipid-targeting therapies, like PPAR agonists and ApoE monoclonal antibodies, offering potential for treatment and prevention.

  • Saved
Lipid metabolism disorder in diabetic kidney disease - PubMed

Lipid metabolism disorder in diabetic kidney disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38742197/

Diabetic kidney disease (DKD), a significant complication associated with diabetes mellitus, presents limited treatment options. The progression of DKD is marked by substantial lipid disturbances, including alterations in triglycerides, cholesterol,...

This research investigates the connection between lipid metabolism disturbances and diabetic kidney disease (DKD), highlighting mechanisms like ferroptosis, lipophagy, and immune modulation, offering new therapeutic pathways for DKD management.

  • Saved

This case report highlights implant failure in a 20-year-old female with idiopathic nephrotic syndrome, long-term steroid use, and its impact on bone metabolism and osseointegration, emphasizing the need for specific clinical guidelines.